STAT1 and cancer: Based on our recent and current findings and in analogy to biomarker assays connected to cancer and transplant rejection (4, 21), a predefined STAT1-target gene signature could be developed as a novel diagnostic tool to monitor and diagnose plaque phenotype in human atherosclerosis.